Variable | Quartile 1N=876 | Quartile 2 N=876 | Quartile 3N=876 | Quartile 4N=876 | P |
---|---|---|---|---|---|
Body weight – kg | 86 (±19) | 82 (±19) | 77 (±19) | 75 (±18) | <0.001 |
NTproBNP – ng/L | 830 (332-1807) | 841 (321-1899) | 1065 (401-2526) | 1742 (701-4064) | <0.001 |
NYHA class III or IV – % | 22% | 25% | 30% | 38% | <0.001 |
Lung crackles O/E - % | 13% | 13% | 18% | 22% | <0.001 |
Peripheral oedema O/E - % | 33% | 34% | 42% | 52% | <0.001 |
Raised JVP O/E - % | 12% | 14% | 14% | 23% | <0.001 |
1 year mortality† - % | 7% | 8% | 10% | 18% | <0.001 |
Legend† - amongst those with at least 1 year follow up (N=3330; 95% of total population)Abbreviations used: D-PVS - Plasma volume status calculated using the Duarte formula; NTproBNP - N-terminal pro-B-type natriuretic peptide; NYHA - New York Heart Association; O/E - on examination.